Stonebridge Financial Planning Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Sell
1,589
-24
-1% -$24.3K 0.54% 61
2025
Q4
$1.73M Sell
1,613
-50
-3% -$47.8K 0.63% 53
2025
Q3
$1.27M Sell
1,663
-75
-4% -$55.8K 0.48% 65
2025
Q2
$1.36M Sell
1,738
-25
-1% -$19.4K 0.57% 57
2025
Q1
$1.46M Sell
1,763
-39
-2% -$32.5K 0.66% 47
2024
Q4
$1.39M Buy
1,802
+109
+6% +$90.3K 0.62% 49
2024
Q3
$1.5M Sell
1,693
-7
-0.4% -$6.29K 0.71% 44
2024
Q2
$1.54M Buy
1,700
+322
+23% +$258K 0.77% 38
2024
Q1
$1.07M Buy
1,378
+344
+33% +$245K 0.57% 50
2023
Q4
$603K Buy
1,034
+594
+135% +$347K 0.35% 78
2023
Q3
$236K Buy
+440
New +$227K 0.15% 126
2022
Q1
Sell
-170
Closed -$42K 255
2021
Q4
$42K Hold
170
0.02% 227
2021
Q3
$45K Hold
170
0.02% 229
2021
Q2
$40K Hold
170
0.02% 232
2021
Q1
$31K Hold
170
0.02% 255
2020
Q4
$29K Hold
170
0.02% 240
2020
Q3
$25K Hold
170
0.02% 246
2020
Q2
$28K Hold
170
0.02% 227
2020
Q1
$25K Buy
170
+70
+70% +$9.62K 0.02% 225
2019
Q4
$13K Buy
+100
New +$11.6K 0.01% 272

Other funds holding LLY

Stonebridge Financial Planning Group's LLY Position: Q1 2026 in Review

Stonebridge Financial Planning Group reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $24.3K and leaving 1,589 shares worth $1.46M. The position accounts for 0.54% of the portfolio, ranked #61.

Stonebridge Financial Planning Group first reported a position in LLY in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.73M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Stonebridge Financial Planning Group held 1,589 shares of Eli Lilly worth $1.46M as of Q1 2026.
  • Stonebridge Financial Planning Group sold 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
  • Eli Lilly made up 0.54% of Stonebridge Financial Planning Group's portfolio in Q1 2026, its #61 holding.
  • Stonebridge Financial Planning Group first reported a position in Eli Lilly in Q4 2019 and has held it in 20 quarters since.
  • Stonebridge Financial Planning Group's Eli Lilly position peaked at $1.73M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2026, filed 8 May 2026.